Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a medical technology company based in Jena, Germany, operating in Germany, Europe, North America, and Asia. It has two segments: Ophthalmology and Microsurgery. The Ophthalmology segment provides diagnostic and treatment products for chronic eye diseases, including slit lamps, refractometers, tonometers, optical coherence tomography and fundus cameras, perimeters, surgical microscopes, biometers, phacoemulsification and vitrectomy equipment, intraocular lenses, and laser eye surgery systems such as the VISUMAX femtosecond laser, along with digital products for clinical data. The Microsurgery segment offers minimally invasive surgical solutions, including surgical visualization, interoperative radiotherapy and pathology, special surgical instruments, digital solutions, and the ZEISS Tumor Workflow. The company serves physicians and hospitals and has a strategic collaboration with Envision Health Technologies Inc. for glaucoma care using gamified virtual reality. Founded in 1846, it is a subsidiary of ZEISS Group.

0DHC.LSE▲

ZEISS Meditec Selects Nirrin Technologies' Atlas System for Hyaluronic Acid Manufacturing

Carl Zeiss Meditec company Hyaltech has purchased an Atlas system from Nirrin Technologies to modernize hyaluronic acid measurement workflows. The Atlas system uses proprietary High-Precision Tunable Laser Spectroscopy to deliver compositional analysis in under one minute without extensive sample preparation, eliminating the need for offline, labor-intensive methods that rely on hazardous chemicals. Hyaltech manufactures over one million hyaluronic acid-based ophthalmic viscosurgical devices annually and will evaluate the platform for production and quality control. Nirrin Technologies CEO Bryan Hassell said the deployment reflects growing industry interest in faster, more actionable analytical measurements closer to manufacturing.

AFX.XETRA ▲

Business Wire·80dRead more →